Effectiveness of Two Different Desensitizing Dental Varnishes
1 other identifier
interventional
66
1 country
1
Brief Summary
Dental varnishes are commonly used to relieve dentin hypersensitivity by forming a protective film that occludes dentinal tubules and reduces fluid flow. This clinical investigation aims to compare the desensitizing effect of a fluoride containing varnish with a fluoride free placebo varnish. Primary and secondary objectives include evaluating short and long term reductions in dentinal hypersensitivity, assessing patient reported outcomes and daily experiences, and monitoring the varnish's tolerability and safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
June 2, 2026
May 1, 2026
8 months
May 27, 2026
May 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction of dentin hypersensitivity
assessed by patient response to an air stimulus using a pain scale (grades 0-4, lower scores mean a better outcome)
1 week
Study Arms (2)
Fluoride-containing varnish
EXPERIMENTALA fluoride-containing varnish is applied to a tooth that is hypersensitive.
Fluoride-free varnish
PLACEBO COMPARATORA fluoride-free varnish is applied to a tooth that is hypersensitive.
Interventions
A fluoride-containing varnish is applied to a tooth that is hypersensitive.
A fluoride-free varnish is applied to a tooth that is hypersensitive.
Eligibility Criteria
You may qualify if:
- Informed Consent signed by the subject
- Age: 18-65 years
- Hypersensitivity assessment scale ≥ Grade 2 in
- two non-neighboring teeth in different quadrants
- The affected teeth are/have: vital, caries-free, received no restorations within the last month
- No change in medication anticipated over the next 3 months (e.g. due to upcoming surgery etc.)
You may not qualify if:
- Contraindications and limitations of the MD as described in the instructions for use.
- Known hypersensitivity or allergy to the device material (especially acrylates, mint flavouring)
- Pregnant or other vulnerable subjects
- Participants with severe systemic disease
- Enrolment of employees of the dental clinic of Ivoclar Vivadent AG
- Recent change in medication concerning Analgesics, NSAIDs, psychotropic drugs, other medications that may alter pain perception
- Intake of analgesics prior to appointment
- Professional desensitizing therapy in the last 3 months
- Bleaching procedures in the last 4 weeks
- Confounding dental conditions at test sites: defective or extensive restorations, abutment teeth for prostheses, recent restorations, pulpitis/periapical pathology.
- Current or recent use of desensitizing toothpastes or mouthrinses (i.e. products specifically marketed for the treatment of dentin hypersensitivity) within 4 weeks prior to enrolment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Internal Clinic Ivoclar Vivadent AG
Schaan, 9494, Liechtenstein
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 27, 2026
First Posted
June 2, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
June 2, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share